F39L (p.Phe39Leu) variant of CYBB (NADPH oxidase 2)
F39L (p.Phe39Leu) in CYBB (NADPH oxidase 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
F39L (p.Phe39Leu) variant details
- p.Phe39Leu
- NCI-TCGA Cosmic COSV1010
- NCI-TCGA Cosmic COSV6608
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available